Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 31, 2023JAMA Network OpenOpen Access

At-Risk Genomic Findings for Pediatric-Onset Disorders From Genome Sequencing vs Medically Actionable Gene Panel in Proactive Screening of Newborns and Children

View Full Paper
Ask AI
Bookmark
Share

Authors

JBJorune BalciunieneUppsala UniversityRLRuby LiuCentre for Omic SciencesLBLora Jh BeanCentre for Omic Sciences

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Balciuniene et al. (2023) studied this question.

synapsesocial.com/papers/6a961870530dc7b9e69fe6eehttps://doi.org/10.1001/jamanetworkopen.2023.26445
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Limitations of exome sequencing in detecting rare and undiagnosed diseases2020 · 110 citations
  2. 2Integration of whole genome sequencing into a healthcare setting: high diagnostic rates across multiple clinical entities in 3219 rare disease patients2021 · 280 citations
  3. 3Real-World Results from Combined Screening for Monogenic Genomic Health Risks and Reproductive Risks in 300 Adults2022 · 9 citations
  4. 4Whole-genome sequencing analysis of CNV using low-coverage and paired-end strategies is efficient and outperforms array-based CNV analysis2018 · 107 citations
  5. 5Principles of Genomic Newborn Screening Programs2021 · 115 citations